Comprehensive Approach to Inflammatory Bowel Disease: Surgery and Internal Medicine in Harmony
DOI:
https://doi.org/10.55204/trc.v3i2.e274Keywords:
Inflammatory Bowel Diseases, Precision Medicine, Multidisciplinary Approach, Therapeutics, Personalized Medicine, TelemedicineAbstract
Introduction: Inflammatory Bowel Disease (IBD) poses intricate challenges that demand a comprehensive approach. From advances in diagnosis to personalized therapies and multidisciplinary strategies, this article delves into the latest research and practical applications in IBD management. The integration of precision medicine, advanced surgical treatment, and patient-centered care strategies reflects the ongoing evolution in understanding and addressing this chronic condition.
Development: The development comprehensively addresses Inflammatory Bowel Disease (IBD), exploring therapeutic strategies in internal medicine and surgery. From aminosalicylates to biologic therapies, the diversity of medical approaches is highlighted. Additionally, common surgical indications, advanced techniques, and preoperative evaluation are discussed.
Practical applications: Future research aims to advance personalized medicine and emerging therapies for Inflammatory Bowel Disease (IBD). Nanotechnology, microbiome modulation, and telemedicine are areas of interest, promising to enhance diagnostic accuracy and therapeutic options.
Conclusions: In conclusion, the comprehensive approach to Inflammatory Bowel Disease (IBD) demands multidisciplinary strategies, from precise diagnosis to personalized treatments. Emerging research points towards promising therapies, transforming management and providing hope for patients.
Downloads
References
Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002 Dec 5;347(23):417-29.
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017 Dec 23;389(10080):1741-55.
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017 Dec 23;389(10080):1756-70.
Frolkis AD, Dykeman J, Negrón ME, deBruyn J, Jette N, Fiest KM, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013 Jul;145(5):996-1006.
de Silva S, Ma C, Proulx MC, Crespin M, Kaplan BS, Hubbard J, et al. Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol. 2011 Jul;9(7):972-80.
Bitton A, Buie D, Enns R, et al. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol. 2012 Mar;107(3):179-94.
Gracie DJ, Williams CJM, Sood R, et al. Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. Am J Gastroenterol. 2016 Oct;111(10):541-551.
Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018 Apr;113(4):481-517.
Selinger CP, Robinson A, Leong RW. Quality of life and patient-reported outcomes in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):567-576.
Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015 Jul;21(7):1982-92.
Frolkis AD, Dykeman J, Negrón ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013 Jul;145(1):996-1006.
Kotze PG, Shen B, Lightner A, et al. Modern management of perianal fistulas in Crohn's disease: future directions. Gut. 2018 Jul;67(7):1181-1194.
Lightner AL, McKenna NP, Tse CS, Raffals LE, Loftus EV, Mathis KL. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations. Aliment Pharmacol Ther. 2018 Feb;47(4):579-585.
Adamina M, Bonovas S, Raine T, et al. ECCO guidelines on therapeutics in Crohn's disease: surgical treatment. J Crohns Colitis. 2020 Mar 12;14(2):155-168.
Iacucci M, Ghosh S. Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease. Therap Adv Gastroenterol. 2011 May;4(3):129-43.
Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012 Jan;6(10):965-90.
Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018 Apr;113(4):481-517.
Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S, et al. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020 Dec;159(4):1102-1118.e3.
Magro F, Gionchetti P, Eliakim R, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017 Jun 1;11(6):649-670.
Fiorino G, Bonifacio C, Allocca M, et al. Bowel healing in inflammatory bowel diseases: a systematic review. J Crohns Colitis. 2019 Nov 12;13(11):1439-1447.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Carlos Eduardo Quezada Narváez, Ana María Gonzalez Erazo, Karol Elizz Rivadeneira Torres, Andrea Estefania Tigselema Maquizaca, Ronnie Eudes García Párraga, Juan Miguel Perez Alvarez, Samijazath Alexander Naranjo Albán
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
